| Mid-Day Update: Stocks Off Lows; Job Ads Rise, But Banking Concerns Weigh - NASDAQ |
|
|
NASDAQ Abbott Laboratories ( ABT ) said that it has received US Food and Drug Administration approval for its RX Herculink Elite Renal Stent System for the treatment of renal artery stenosis, or the narrowing of the main arteries supplying blood to the |